Abstract B118: A phase 1, open-label multiple dose escalation trial to determine safety and tolerability of once daily OPB-111077 in subjects with advanced cancer von Cote, Gregory, Papadopoulos, Kyriakos, Patnaik, Amita, Rascoe, Drew, Smith, Lon, Bullock, Andrea, Flaherty, Keith, Shapiro, Geoffrey, Berlin, Jordan, Monga, Manish, Habermann, Thomas, Witzig, Thomas, Lin, Chester, Tsai, Lin-Feng, Elekes, Agnes, Ohi, Naoto, Tatsumi, Kunihiko, Tolcher, Anthony

Volltext